South Africa has put a hold on the rollout of the AstraZeneca COVID-19 vaccine.
Health Minister Dr Zweli Mkhize last night announced that a team of experts would give guidance on the way forward with this vaccine.
Early scientific data released on Sunday revealed that the vaccine offered “minimal protection” against mild disease for people infected with the second variant of the coronavirus discovered at the end of last year.
Clinical trial data from the AstraZeneca COVID-19 vaccine study locally revealed that it had a 22% efficacy against the 501Y.V2 coronavirus variant.
Minister Mkhize said that at the time that government acquired the vaccines, this clinical trial data had not been concluded.
More Stories
Eskom Concedes That Outrage Over Power Cuts Warranted
Electricity Minister To Visit All Power Stations
Over 500 Arrested Nationwide During Protest Action
Malema Rubbishes Concerns That EFF Nationwide Protest Will Turn Violent
Santaco Says Taxi Industry Will Operate As Normal
Government Ready To Deal With Any Eventuality
Nersa Sticks By 18.65% Tariff Increase
Anarchy Will Not Be Allowed In SA – Ramaphosa
It’s Anarchy Of The Highest Order – Mbalula
Cape Town Stockpiling Diesel For Winter
ANC Is Not Corrupt – Mbalula
No Timeline On Phala Phala Probe – Lebeya